VENTED COVER PLATE FOR AN ARRAY OF SYRINGES
20190041132 ยท 2019-02-07
Inventors
- Kevin Stuart McCann (Fort Collins, CO, US)
- Herbert Robert Brinkman (Fort Collins, CO, US)
- John Milton Downing (Fort Collins, CO, US)
Cpc classification
F26B5/06
MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
B65D51/16
PERFORMING OPERATIONS; TRANSPORTING
A61K38/09
HUMAN NECESSITIES
A61J1/2096
HUMAN NECESSITIES
International classification
F26B5/06
MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
A61M5/00
HUMAN NECESSITIES
A61J1/20
HUMAN NECESSITIES
A61K38/09
HUMAN NECESSITIES
F26B25/14
MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
B65D51/16
PERFORMING OPERATIONS; TRANSPORTING
Abstract
A cover plate for use in lyophilization processes is provided. The cover plate includes a base portion and a plurality of protuberances which project from the base portion. The protuberances are adapted to fit in one or more delivery containers, such as syringe barrels. The cover plate permits the escape of vapor from the one or more delivery containers during a lyophilization process. In addition, the cover plate prevents the escape of lyophilizate from the one or more delivery containers during a lyophilization process. Vent features provided to provide enhanced and preferred venting operations during lyophilization processes.
Claims
1. A cover plate adapted for communication with a plurality of delivery containers during a lyophilization process, the cover plate comprising: a base portion comprising a length and a width; a plurality of protuberances extending from the base portion and distributed along at least one of the length and the width of the base portion; each of the plurality of protuberances adapted to extend at least partially into a delivery container; each of the plurality of protuberances comprising a plurality of extensions distributed about a circumference of the protuberance; at least one vent provided between the extensions, the at least one vent provided to allow at least one of a gas, a vapor, and a fluid to flow therethrough; and wherein the cover plate substantially prevents the escape of a lyophilizate from the one or more delivery containers during a lyophilization process.
2. The cover plate of claim 1, wherein each of the plurality of protuberances comprises a frustoconical member.
3. The cover plate of claim 1, wherein the protuberances comprise a first portion and a second portion, and wherein the extensions are provided proximal to an intersection of the first portion and the second portion.
4. The cover plate of claim 1, wherein the extensions comprise a plurality of rectangular extensions.
5. The cover plate of claim 1, wherein the protuberances are provided in an array.
6. (canceled)
7. A system for handling a plurality of delivery containers during a lyophilization process, the system comprising: a tub; a rack operable to suspend a plurality of containers in an upright position such that an opening of each of the containers faces toward a top of the tub; a cover plate comprising a plurality of protuberances distributed along at least one of a length and a width of the cover plate, wherein each of the plurality of protuberances is adapted to extend at least partially into a container; wherein each of the plurality of protuberances comprises a plurality of extensions distributed about a circumference of the protuberance, each of the plurality of extensions being operable to rest on a container; at least one gap provided between the extensions, the at least one gap provided to allow at least one of a gas, a vapor, and a fluid to flow therethrough; and wherein the cover plate substantially prevents the escape of a lyophilizate from the one or more containers during a lyophilization process.
8. The system of claim 7, wherein the rack comprises a flange and wherein the flange comprises a contact surface for placing the rack in contact with the tub.
9. The system of claim 7, wherein the plurality of extensions extend from an outer surface of the protuberances and provide an irregular shape to the outer surface of the protuberances.
10. The system of claim 7, wherein each of the plurality of protuberances comprises a frustoconical member.
11. The system of claim 7, wherein the protuberances comprise a first portion and a second portion, and wherein the extensions are provided proximal to an intersection of the first portion and the second portion.
12. The system of claim 7, wherein the extensions comprise a plurality of rectangular extensions.
13. The system of claim 7, wherein the protuberances are provided in an array.
14. (canceled)
15. The system of claim 7, wherein the delivery containers contain leuprolide acetate.
16. A cover plate adapted for covering a plurality of syringe barrels during a lyophilization process, the cover plate comprising: a base portion comprising a length and a width; a plurality of protuberances distributed along the length and the width of the base portion, and wherein each of the plurality of protuberances extend from the base portion; each of the plurality of protuberances comprising a frustoconical protuberance adapted to extend at least partially into a syringe barrel; a plurality of extensions operable to provide gaps between the protuberances and associated syringe barrels, and wherein the gaps provide vents to allow at least one of a gas, a vapor, and a fluid to escape the syringe barrel.
17. The cover plate of claim 16, wherein the extensions extend from a flange of the base portion.
18. The cover plate of claim 16, wherein the extensions comprise a plurality of rectangular extensions provided on the protuberances.
19. The cover plate of claim 16, wherein the protuberances are provided in an array.
20. The cover plate of claim 16, wherein each of the plurality of extensions comprises at least three extensions.
21. The cover plate of claim 16, wherein the extensions comprise blocked-shaped extensions on the protuberances.
22. The cover plate of claim 16, wherein distal ends of the extensions comprise support surfaces.
23. (canceled)
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Those of skill in the art will recognize that the following description is merely illustrative of the principles of the disclosure, which may be applied in various ways to provide many different alternative embodiments. This description is made for illustrating the general principles of the teachings of this disclosure invention and is not meant to limit the inventive concepts disclosed herein.
[0027] The accompanying drawings, which are incorporated in and constitute a part of the specification, illustrate embodiments of the disclosure and together with the general description of the disclosure given above and the detailed description of the drawings given below, serve to explain the principles of the disclosures.
[0028]
[0029]
[0030]
[0031]
[0032]
[0033]
[0034]
[0035] It should be understood that the drawings are not necessarily to scale. In certain instances, details that are not necessary for an understanding of the disclosure or that render other details difficult to perceive may have been omitted. It should be understood, of course, that the disclosure is not necessarily limited to the particular embodiments illustrated herein.
DETAILED DESCRIPTION
[0036] Cover plates of the present disclosure can be constructed from any suitable material. The material, or combination of materials, is preferably resistant to the temperature and pressure changes that exist during the lyophilization process. In addition, the material is preferably durable, inexpensive, and reusable. Suitable materials include, but are not limited to plastics, TEFLON, rubber, fiberglass, glass, and any combination thereof. Plastic is one preferable material for making the cover plate, as it is relatively light, durable, easy to use and relatively inexpensive.
[0037] As shown in
[0038]
[0039]
[0040]
[0041] In preferred embodiments, a plurality of extensions 20 are provided that are evenly spaced about a circumference of the protuberance 14 such that each of the extensions are adapted to rest on an open end of a delivery container and each protuberance 14 is evenly supported on or in the delivery container. The extensions 20 extend from an outer surface of the protuberances and provide an irregular shape to the outer surface of the protuberances. In some embodiments, the protuberances 14 comprise triangular, circular, irregular, or other extensions with at least one gap provided between extensions. In one alternative embodiment, a protuberance is provided with one or more flutes or recesses such that the protuberance rests in and/or on a delivery container and vapor or gas is allowed to escape from the delivery container and the restrictor plate through the flute(s) or recess(es). The flutes are contemplated as comprising slots or depressions in the sidewall(s) of the protuberances, wherein the sidewall of the protuberances contact the syringe barrel, and the flutes extend above and below the rim or lip of the syringe barrel to allow for egress of lyophilized contents. The flutes may be of various shape including, for example, oval, circular, tear-drop shaped, etc.
[0042]
[0043] In various embodiments, the cover plate comprises between 1 to about 300, 1 to about 200, 50 to about 150 or, preferably, about 75 to about 125 protuberances 14. As shown and described, the protuberances serve as a non air-tight stopper, plug or cap over a delivery container, thereby preventing the escape of lyophilizate from the delivery container during lyophilization. In addition, suitable protuberances can catch lyophilizate that contacts the protuberance 14 during lyophilization. Accordingly, a suitable protuberance 14 prevents lyophilizate from one delivery container from being introduced into another delivery container during lyophilization, thereby contaminating the contents of one delivery container with the contents of another delivery container. In addition, a suitable protuberance 14 permits lyophilization to proceed by allowing vapor to pass from the interior of the delivery container to the exterior of the delivery container during lyophilization.
[0044] The protuberances 14 preferably fit within an opening 8 of the delivery container 7 to prevent the escape of lyophilizate from the delivery container 7 and to allow vapor to pass from the interior of the delivery container 7 to the exterior of the delivery container 7 during lyophilization. As such, the protuberance 14 can have any suitable shape. The protuberance 14 can assume any suitable shape which generally corresponds with or is received within the shape of the opening 8 of the delivery container 7, so long as the protuberance 14 cooperates with the opening 8 of the delivery container 7. The protuberance 14 may be shaped in any suitable manner provided it caps or plugs the opening 8 of the delivery container 7 and permits the passage of vapor during lyophilization. As such, the shape of the protuberance 14 can depend upon the shape of the opening 8 of the delivery container 7.
[0045] Specifically, the protuberance 14 can be spherically shaped, conically shaped, frustoconically shaped or cylindrically shaped. In addition, the cylindrically shaped protuberance 14 can be tapered. The protuberance 14 can be tapered from a first end of the protuberance proximal to the base portion 16 to a second end of the protuberance provided distally therefrom and adapted to be inserted into a delivery container. Alternatively, the protuberance(s) 14 can be tapered from the lowest point vertically on the protuberance 14 after the cover plate 12 is placed atop a tub.
[0046] In various embodiments, the protuberance(s) comprise a length as small as hundredths of an inch or as large as several inches, depending upon the size and depth of delivery containers. Generally, the longer the protuberances 14, the more firmly in place they will keep the cover plate 12 relative to the delivery containers 8 during lyophilization. In one embodiment, a length of each protuberance 14 is between about 1.0 inch and about 2.0 inches, and more preferably is about 1.4 inches to about 1.6 inches.
[0047] The suitable length of the protuberance 14 can typically depend upon the length of the delivery containers and the amount of contents in the delivery containers. Preferably, the suitable length of the protuberance 14 will minimize or lessen the occurrence of the contents of the delivery containers 7 from obtaining sufficient kinetic energy to be ejected out of the delivery containers 7. The suitable length of the protuberance 14 will minimize or lessen this occurrence by extending within about 0.5 inch, within about 0.25 inch, or within about 0.1 inch of the contents of the delivery containers 8.
[0048] In various embodiments, the spacing and positioning of the protuberances 14 are provided to correspond to the spacing and positioning of wells or delivery containers 7 to which the cover plate 12 is designed to cooperate or mate with. Accordingly, this spacing or positioning can be varied. In one embodiment, a distance between axial centers of adjacent protuberances in the same row, can be about 0.5 inch to about 0.9 inch, and more specifically can be about 0.6 inch to about 0.7 inch. The distance horizontally between axial centers of the nearest two protuberances 30 in adjacent rows, can be about 0.25 inch to about 0.5 inch, and more specifically can be about 0.3 inch to about 0.4 inch. The distance horizontally between axial centers of the nearest two protuberances 30 in adjacent rows, can be about 0.4 inch to about 0.9 inch, and more specifically can be about 0.6 inch to about 0.7 inch.
[0049] As shown in
[0050]
[0051] Delivery containers as disclosed and described herein may include any receptacle in which a pharmaceutical can be lyophilized. Specifically, the delivery containers may comprise ampules, vials, or syringes. Syringes are specifically suitable for lyophilizing pharmaceuticals whose ultimate use will be administration from a syringe. The pharmaceutical can be reconstituted, if necessary, in the syringe in which the pharmaceutical was lyophilized. Accordingly, syringes are especially suitable for lyophilizing an injectable pharmaceutical (i.e., medication), since the medication is ultimately administered from the syringe.
[0052] The syringe can be manufactured from any suitable material. Suitable materials are those materials that are resistant to the temperature and pressure changes that exist during the lyophilization process. The material can be durable and inexpensive. Suitable materials include plastics, glass, and any combination thereof.
[0053] Specifically, the syringe can be manufactured from plastic. Plastic syringes are generally stronger than glass syringes. The increased strength of plastic results in a more durable syringe. The increased durability allows for a safer syringe as a plastic syringe will not break as easily upon administration as compared to a glass syringe. As such, fewer health care professionals will become injured while reconstituting and administering injectable medications in a plastic syringe as compared to a glass syringe.
[0054] Due to the increased strength of plastic syringes, the bore size of plastic syringes is routinely larger than those of comparable glass syringes, thereby decreasing the force required to use the plastic syringe. This is especially useful when reconstituting an injectable medication with a very viscous diluent or for syringe-to-syringe reconstitution. See, U.S. patent application Ser. No. 09/405,463 filed on Sep. 24, 1999.
[0055] The syringe can be disposable or can be reusable. Disposable syringes are commercially available and are usually constructed from plastic or glass. Disposable syringes are popular due to their convenience and because they are relatively inexpensive. A suitable disposable plastic syringe of the present invention is manufactured by Becton Dickinson & Company in what is known as a Hypak configuration and is disclosed in U.S. Pat. No. 4,758,230, for example.
[0056] The solution containing the pharmaceutical can be cooled to a frozen solid prior to lyophilization. The solution can be cooled by any suitable cooling means (e.g., convention, conduction or radiation). Specifically, the solution can be cooled by convection.
[0057] After the solution is cooled to a frozen solid, a partial vacuum is applied to the lyophilizing apparatus to provide a partial vacuum within the lyophilizing apparatus (i.e., within the inside of the delivery container and on the outside of the delivery container). The partial vacuum can be applied to the solution, in the frozen state, until essentially all of the solvent is removed (i.e., to dryness).
[0058] After lyophilization is completed, the tub can be removed from the lyophilization apparatus. The cover plate 12 can be removed from the delivery container 7 and examined for any retained lyophilizate. If the protuberances 14 of the cover plate 12 contains any lyophilizate, each delivery container 8 from which the lyophilizate originated can be discarded or recycled and the lyophilizate can be recycled or discarded. If any pharmaceutical leaves a delivery container and is captured on the restrictor plate, the amount of lyophilized pharmaceutical remaining in the delivery container is unknown. Thus, any delivery container losing any lyophilizate captured by the cover plate can be discarded or recycled. Accordingly, the cover plate is removed from on top of the delivery container and examined for any retained lyophilizate. If the cover plate contains any lyophilizate, each delivery container from which the lyophilizate originated can be discarded or recycled.
[0059] After lyophilization, the opening 8 of any undiscarded delivery container 7 can be sealed for storage. The delivery container 7 can be sealed with any suitable sealing device known for sealing delivery containers 7. Where the delivery container 7 is a syringe, the proximal opening of the syringe barrel can be sealed with the plunger of the syringe.
[0060] The embodiment of
[0061] In various embodiments, methods of performing lyophilization are provided. In certain embodiments, methods of lyophilization comprise providing a cover plate with a plurality of protuberances as shown and described herein.
[0062] For illustrative purposes, a method of lyophilization according to one embodiment of the present disclosure is provided as follows: lyophilization of leuprolide acetate is achieved by providing a solution containing leuprolide acetate in a solvent, e.g. water, prepared by mixing leuprolide acetate in water until dissolved. A tub of syringes is opened so the opening of the proximal end of each syringe is exposed. Leuprolide acetate solution with approximately 7.5 mg of leuprolide acetate is filled into each syringe by means of a pipette (for example) through the opening of the proximal end of each syringe. This procedure is repeated with three additional tubs of syringes into which leuprolide acetate solution with approximately 22.5, 30, or 45 mg of leuprolide acetate is filled. When the syringes in a tub are filled with the leuprolide acetate solution, the tub containing the plurality of syringes is placed on a shelf of a lyophilizing apparatus. The syringes are then covered with a cover plate (see
[0063] The tub is removed from the lyophilizing apparatus. The cover plate is removed from the opening of the syringes. Each area of the covering plate is examined for captured lyophilizate and the syringes from which any such captured lyophilizate came are discarded. Plunger tips are installed into the opening of the proximal end of the syringes, and plunger rods are screwed into the corresponding plunger tips. The syringes are now ready for reconstitution.
[0064] In the following example, lyophilization experiments were conducted to determine the effects of syringe occlusion: syringes were intentionally occluded to observe effects of restricting water vapor flow from the syringe during lyophilization. Syringes were occluded by creating a vent through stoppered syringes using needles of varied gauges. Specifically, partial occlusion was accomplished by piercing syringe stoppers with a 27 gauge needle (0.21 mm nominal ID), a 20 gauge needle (0.63 mm nominal ID), and a 16 gauge needle (1.2 mm nominal ID).
[0065] The syringes were filled with a leuprolide acetate solution by hand using a micropipette and were weight checked. The syringes were loaded into tubs and were subjected to a lyophilization cycle such as those described herein. Meltback or failed lyophilization was observed in syringes that were occluded and lacked sufficient venting. Specifically, it was observed that it is desirable to have a vent or opening of at least approximately 1.0 mm.sup.2 to facilitate proper lyophilization. It will be recognized, however, that the present disclosure is not limited to any particular minimum area for a vent feature. In certain embodiments, however, it is preferable to provide at least approximately 1.0 mm.sup.2 of vent area between an otherwise covered or closed end of a delivery container that is subjected to a lyophilization process.
[0066] The results of this experiment showed that the degree of occlusion for the syringes impacts lyophilization. When vent size was varied from 0.21 mm (27G) to 1.2 mm (16G) using hypodermic needles, the degree of success of lyophilization was also varied. Syringes with 0.21 mm vents showed little if any lyophilization, while those with 1.2 mm vents dried normally.
[0067] While various embodiments of the present invention have been described in detail, it is apparent that modifications and alterations of those embodiments will occur to those skilled in the art. However, it is to be expressly understood that such modifications and alterations are within the scope and spirit of the present invention. Further, the invention(s) described herein are capable of other embodiments and of being practiced or of being carried out in various ways. In addition, it is to be understood that the phraseology and terminology used herein is for the purposes of description and should not be regarded as limiting. The use of including, comprising, or adding and variations thereof herein are meant to encompass the items listed thereafter and equivalents thereof, as well as, additional items.